trending Market Intelligence /marketintelligence/en/news-insights/trending/CMbVga7k74MzHOxc18W2PA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

TrovaGene director to resign

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


TrovaGene director to resign

TrovaGene Inc. said that Stanley Tennant will resign as a director, effective Dec. 31.

Tennant's resignation is due to personal reasons and not a result of any disagreement with the company, its management or board, TrovaGene said in a Dec. 10 regulatory document.

San Diego-based Trovagene is a clinical-stage biopharmaceutical company focused on developing oncology therapeutics.